Diabetes Risk Commonly Clustered Within Households
By Lori Solomon HealthDay Reporter

TUESDAY, Aug. 19, 2025 -- Diabetes risk is commonly clustered within households, according to a study scheduled to be presented at the annual meeting of the European Association for the Study of Diabetes, held from Sept. 15 to 19 in Vienna.
Tainayah Thomas, Ph.D., M.P.H., from Stanford University in Palo Alto, California, and colleagues used electronic health record (EHR) and administrative data to evaluate diabetes risk factors among household members of 356,626 adult patients with prediabetes.
The researchers found that 51.8 percent of the index patients with prediabetes (mean age, 50.5 years) were living in multiresident households, and more than 75 percent of multiresident households had at least one household member with additional diabetes risk factors (364,563 co-residing household members with a mean age of 41.5 years for adult household members and 10.2 years for child household members). Among household members, diabetes risk factors were identified in nearly two-thirds of adults (64.6 percent) and one-third of children (35.0 percent), with overweight/obesity being the most common risk factor present (54.9 percent of adult and 34.1 percent of child household members). Among adult household members, dysglycemia was present in 32.3 percent, with 20.3 percent showing prediabetes lab results and 12 percent having evidence of diabetes.
"All health systems could use this approach as a data-driven strategy to better and more systematically identify people at high risk for diabetes," Thomas said in a statement. "This strategy could allow health systems to identify and tailor diabetes prevention messaging and programs to entire households instead of just individuals."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-20 06:00
Read more

- Elevated INR in Older Adults on Warfarin May Not Be Tied to Risk for Brain Bleeding After Head Trauma
- Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma
- Many Not Up to Date With Vaccines Would Accept Shots During ED Visits
- Rate of Sexual Dysfunction Similar in Middle-Aged, Older Women
- RFK Jr. Cancels $500M in mRNA Vaccine Research Projects
- FDA Approves Apellis’ Empaveli (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions